Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

The data shows that the average rate of adolescents starting treatment with the Novo Nordisk (NYSE: NVO) drug increased by 50 ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on Monday that its experimental drug, when combined with Novo ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...

CAT Sims has opened up about turning to Mounjaro after quitting booze and drugs lead her turning to food and piling on three ...

New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...

Doctors are continuing to issue warnings regarding the illicit use of Ozempic, Wegovy and Mounjaro as weight loss injections, ...

After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...